IP Library Granted Patent US 10,802,298
Granted Patent B2
US 10,802,298 · App. 15/639,514 · Granted Oct 13, 2020

Eye mounted device for controlling focusing disorders

Inventors: Kuang-mon Ashley Tuan (Mountain View, CA); Michael Frank Deering (Los Altos, CA)
Assignee: Tectus Corporation
G02C11/10A61B3/0008A61B3/107A61H5/00A61H5/005G02C7/04G03B21/145G02C2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,802,298
App. No.
15/639,514
Granted
Oct 13, 2020
Kind
B2
Abstract

An eye mounted display presents defocused images to patients to affect their eyeball development and control focusing disorders such as myopia or hyperopia. For example, images may be projected with peripheral myopic defocus in order to control myopia. Images may be projected with peripheral hyperopic defocus in order to control hyperopia.

Claims (17)

1. A method of controlling eye focusing disorders in a patient, the method comprising:

diagnosing an eye focusing disorder for the patient; and

having the patient wear an eye mounted treatment device comprising:

a contact lens; and

a first group of one or more femtoprojectors mounted in the contact lens, the first group projecting light into the patient's eye, wherein said light is defocused to form images in front of or behind the patient's retina, and the defocus is selected based on stimulating eye growth to control the diagnosed eye focusing disorder.

2. The method of claim 1 where the patient is less than 18 years of age.

3. The method of claim 1 where the diagnosed eye focusing disorder is myopia and the first group projects light into the patient's eye with peripheral myopic defocus to form images in front of a peripheral area of the patient's retina.

4. The method of claim 1 where the diagnosed eye focusing disorder is hyperopia and the first group projects light into the patient's eye with peripheral hyperopic defocus to form images behind a peripheral area of the patient's retina.

5. The method of claim 1 where the diagnosed eye focusing disorder is accommodative lag and the first group projects light into the patient's eye with central myopic defocus to form images in front of a central area of the patient's retina.

6. The method of claim 1 further comprising:

measuring a shape of the patient's eye; and

selecting from a plurality of eye mounted treatment devices with different focus positions for the first group, based on the focus position of the first group relative to the shape of the patient's eye.

7. The method of claim 1 wherein the eye mounted treatment device further comprises a second group of one or more femtoprojectors mounted in the contact lens, the second group projecting light into the patient's eye, said light focused on the patient's retina.

8. The method of claim 2 wherein the second group projects light to a center area of the patient's retina, and the first group projects light to a peripheral area of the patient's retina.

9. The method of claim 2 wherein both the first and second group project light to a center area of the patient's retina.

10. The method of claim 1 wherein the first group also projects light with enhanced brightness in a blue region of a visible spectrum.

11. The method of claim 1 wherein the first group projects light into the patient's eye with defocus of not more than three diopters.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2019
From: SPY EYE, LLC
To: TECTUS CORPORATION
Reel/Frame 049262/0930 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2017
From: TUAN, KUANG-MON ASHLEY; DEERING, MICHAEL FRANK
To: SPY EYE, LLC
Reel/Frame 043350/0815 →
Continuity (2)
Provisional Application 62363127 · Jul 15, 2016
Related Publication 20180017814A1 · Jan 18, 2018